Q: What prompted your bipartisan investigation into private equity’s stake in hospital ownership? A: In the last Congress, I launched a bipartisan inquiry to dig into the impact that private equity ...
Expanded partnership highlights the parties' emerging leadership in targeted alpha therapies (TAT), leveraging Orano Med's expertise in the development of 212 Pb-based TAT and vast proprietary supply ...